Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
IMA-638
DRUG
3 trials
Sponsors
Wyeth is now a wholly owned subsidiary of Pfizer
, Pfizer
Conditions
Asthma
Healthy
Phase 1
Study Evaluating IMA-638 in Asthma
Completed
NCT00339872
Wyeth is now a wholly owned subsidiary of Pfizer
Asthma
Start: 2006-02-28
End: 2007-04-30
Updated: 2007-12-05
Study Evaluating IMA-638 in Healthy Japanese
Completed
NCT00340327
Wyeth is now a wholly owned subsidiary of Pfizer
Healthy
Start: 2006-06-30
End: 2007-07-31
Updated: 2007-12-05
Phase 2
Study Evaluating the Effect of IMA-638 in Subjects With Persistent Asthma
Completed
NCT00425061
Pfizer
Asthma
Start: 2007-02-28
End: 2008-08-31
Updated: 2015-01-14
Related Papers
RPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 α1 and α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human Study.
2017-04-28
34 citations